Clinical significance of side population in ovarian cancer cells

Shinji Hosonuma, Yoichi Kobayashi, Satoshi Kojo, Haruka Wada, Ken ichiro Seino, Kazushige Kiguchi, Bunpei Ishizuka

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Recently, accumulating evidence has suggested that tumors, including ovarian cancer, are composed of a heterogeneous cell population with a small subset of cancer stem cells (CSCs) that sustain tumor formation and growth. The emergence of drug resistance is one of the most difficult problems in the treatment of ovarian cancer, which has been explained recently by the potential of CSCs to have superior resistance against anti-cancer drugs than conventional cancer cells. In this study, we expanded this line of study to examine whether this phenomenon is also observed in clinical specimens of ovarian cancer cells. In total we could analyze 28 samples out of 60 obtained from ovarian cancer patients. The clinical samples were subjected to testing of the expression of side population (SP) as a CSC marker, and according to the presence of SP (SP+) or absence of SP (SP-), clinicopathological significances were analyzed. Although there was no statistical significance, there were more SP+s in recurrent cases as well as in ascitic and peritoneal dissemination than in primary tumor of the ovary. There was no correlation between SP status and FIGO staging. In 19 cases of those who could be followed more than 6 months from initial therapy, there were 8 cases of recurrence or death from disease, and all of these were SP+. On the other hand, in 11 cases of disease-free survivors, 6 were SP+. There was a significant difference in prognosis between SP+ and SP- (p = 0.017). Although this study was limited, it revealed that SP could be contained more in recurrent or metastatic tumors than in primary tumors, and also that the presence of SP could be a risk factor of recurrence in ovarian cancer. Therefore, a novel therapeutic strategy targeting SP could improve the prognosis of ovarian cancer.

Original languageEnglish
Pages (from-to)9-12
Number of pages4
JournalHuman Cell
Volume24
Issue number1
DOIs
Publication statusPublished - Mar 1 2011
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Cell Biology
  • Cancer Research

Fingerprint Dive into the research topics of 'Clinical significance of side population in ovarian cancer cells'. Together they form a unique fingerprint.

  • Cite this

    Hosonuma, S., Kobayashi, Y., Kojo, S., Wada, H., Seino, K. I., Kiguchi, K., & Ishizuka, B. (2011). Clinical significance of side population in ovarian cancer cells. Human Cell, 24(1), 9-12. https://doi.org/10.1007/s13577-010-0002-z